Comparative assessment of different methods of wound defects closure in patients with diabetic foot syndrome
DOI:
https://doi.org/10.11603/2414-4533.2019.3.10547Keywords:
diabetes mellitus, diabetic foot syndrome, dermal equivalent, platelet-rich plasmaAbstract
The aim of the work: to improve the results of surgical treatment of patients with diabetic foot syndrome using modern methods of wound defects closure.
Materials and Methods. The results of complex examination and treatment of 67 patients with diabetic foot syndrome were performed. The observed patients were divided into: comparison group – 31 (46.27 %) patients, who underwent “classic” autodermoplasty and the main group – 36 (53.73 %) patients. Among the last in 17 (47.22 %) the wound defect was closed with the help of the dermal equivalent, and in 19 (52.78 %) was used the PRP technique. In accordance with the clinical forms of the diabetic foot syndrome, the neuropathic form was indicated in 30 (44.78 %) patients and the neuro-ischemic form in 37 (55.22 %) patients. Based on the results obtained using various methods of defect closure, the area and rate of wound healing were calculated.
Results and Discussion. Analyzing the results of the use of the equivalent of the dermis, the following was established: for 20 days of treatment the area of the wound is 1.76 times smaller than the area of the wound in patients without the use of the equivalent of the dermis; the wound healing rate is 1.41 higher. When using the PRP membrane, it is found that by the 20th day of treatment the wound area is 2.25 times smaller than the wound area in patients without using the PRP membrane, and the wound healing rate is 1.45 higher. The use of cell-tissue technologies and platelet-rich membrane with growth factors in topical wound defect treatment allows healing and improves treatment outcomes by accelerating the time of epithelialization over conventional therapy.
References
Zheng, Yan, Sylvia H. Ley, Frank B. Hu. (2018). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology 14 (2), 88. DOI: https://doi.org/10.1038/nrendo.2017.151
Boulton, Andrew J.M. (2005). The global burden of diabetic foot disease. The Lancet, 366 (9498), 1719-1724.
Zelen, C., & Armstrong, D.G. (2019). 45-LB: Results of a pilot evaluation of a novel autologous homologous skin construct treatment of diabetic foot wounds refractory to conventional treatments. DOI: https://doi.org/10.2337/db19-45-LB
Weller C.D., Gardiner, E.E., Arthur, J.F., Southey, M., & Andrews, R.K. (2019). Autologous platelet-rich plasma for healing chronic venous leg ulcers: Clinical efficacy and potential mechanisms. International Wound Journal, 16 (3), 788-792. DOI: https://doi.org/10.1111/iwj.13098
Tsachiridi, M., Galyfos, G., Andreou, A., Sianou, A., Sigala, F., Zografos, G., & Filis, K. (2019). Autologous Platelet-Rich Plasma for Nonhealing Ulcers: A Comparative Study. Vascular Specialist International, 35 (1), 22. DOI: https://doi.org/10.5758/vsi.2019.35.1.22
Cheun, T.J., Haidar, G.M., & Toursarkissian, B. (2019). Peripheral Arterial Disease and Diabetes Mellitus. In The Diabetes Textbook. Springer, Cham. DOI: https://doi.org/10.1007/978-3-030-11815-0_48
Miron R.J., Fujioka-Kobayashi, M., Bishara, M., Zhang, Y., Hernandez, M., & Choukroun, J. (2017). Platelet-rich fibrin and soft tissue wound healing: a systematic review. Tissue Engineering Part B: Reviews. 23 (1), 83-99. DOI: https://doi.org/10.1089/ten.teb.2016.0233
Bello, Y.M., Falabella, A.F., & Eaglstein, W.H. (2001). Tissue-engineered skin. Current status in wound healing. Am. J. Clin. Dermatol., 2 (5), 305-313 DOI: https://doi.org/10.2165/00128071-200102050-00005
Hasenstein, Todd A., Timothy Greene, C., Van Jennifer, Andrew Meyr, J. (2019). Soft tissue reconstruction with diabetic foot tissue loss. Clinics in Pediatric Medicine and Surgery, 36, 3, 425-440. DOI: https://doi.org/10.1016/j.cpm.2019.02.006
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish their work in Hospital Surgery. Journal by L. Ya. Kovalchuk agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)